Antiviral Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Mechanism of Action (Protease Inhibitors, Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Others); Application (Hepatitis, HIV, Influenza, Herpes, Coronavirus Infection, Others); Type (Branded, Generic); Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00004068 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Antiviral drugs are a type of medicine that is used to treat viral infections like HIV, herpes, hepatitis, and influenza. These antiviral drugs are generally administered in the form of vaccine but can also be given in the form of tablets, capsules, powders. Additionally, most of these drugs are utilized for specific viral infections, while a few (broad-spectrum antiviral drugs) are effective against a wide range spectrum of viruses. The global market for antiviral drugs is being driven by a rise in the rate of viral infections. In addition, the market is expected to grow due to an increase in R&D activities and the development of newer and advanced formulations, such as vaccines and combination therapy.

MARKET SCOPE

The "Global Antiviral Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antiviral drugs market with detailed market segmentation by mechanism of action, application, type and distribution channel. The report provides key statistics on the market status of the leading antiviral drugs market players and offers key trends and opportunities in the market.MARKET SEGMENTATION

  •   Based on mechanism of action the market is segmented as, protease inhibitors, nucleotide polymerase inhibitor, reverse transcriptase inhibitors and others.
  •   Based on application the market is segmented as, hepatitis, HIV, influenza, herpes, corona virus infection and others.
  •   Based on type the market is segmented as, branded and generic.
  •   Based on distribution channel the market is segmented as, hospitals, retail pharmacies and online pharmacies.

MARKET DYNAMICS
Drivers:

  •   Increasing prevalences of viral infections across the globe is the key driver for the market growth.
  •   Extensive R&D efforts to develop and formulate advanced antiviral therapies, combination antivirus therapies.
  •   Increase in awareness about treatment of viral infetions is also expected to spur the market growth.

Restraints:

  •   However, risk of side effects after prolonged drug therapy is expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antiviral drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antiviral drugs market in these regions.

IMPACT OF COVID-19 ON ANTIVIRAL DRUGS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the antiviral drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antiviral drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antiviral drugs in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antiviral drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   F. Hoffmann-La Roche Ltd
  •   GlaxoSmithKline plc
  •   Merck Sharp and Dohme Corp
  •   Gilead Sciences, Inc
  •   Bristol-Myers Squibb Company
  •   Johnson and Johnson Services, Inc.
  •   Mylan N.V (Viatris)
  •   Dr. Reddy's Laboratories Ltd
  •   Cipla Inc
  •   Aurobindo Pharma USA
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Antiviral Drugs Market - By Mechanism of Action
    1.3.2 Antiviral Drugs Market - By Application
    1.3.3 Antiviral Drugs Market - By Type
    1.3.4 Antiviral Drugs Market - By Distribution Channel
    1.3.5 Antiviral Drugs Market - By Region
    1.3.5.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. ANTIVIRAL DRUGS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. ANTIVIRAL DRUGS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. ANTIVIRAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
    6.1. ANTIVIRAL DRUGS - GLOBAL MARKET OVERVIEW
    6.2. ANTIVIRAL DRUGS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - MECHANISM OF ACTION
    7.1. OVERVIEW
    7.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
    7.3. PROTEASE INHIBITORS
    7.3.1. Overview
    7.3.2. Protease Inhibitors Market Forecast and Analysis
    7.4. NUCLEOTIDE POLYMERASE INHIBITOR
    7.4.1. Overview
    7.4.2. Nucleotide Polymerase Inhibitor Market Forecast and Analysis
    7.5. REVERSE TRANSCRIPTASE INHIBITORS
    7.5.1. Overview
    7.5.2. Reverse Transcriptase Inhibitors Market Forecast and Analysis
    7.6. OTHERS
    7.6.1. Overview
    7.6.2. Others Market Forecast and Analysis
    8. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. HEPATITIS
    8.3.1. Overview
    8.3.2. Hepatitis Market Forecast and Analysis
    8.4. HIV
    8.4.1. Overview
    8.4.2. HIV Market Forecast and Analysis
    8.5. INFLUENZA
    8.5.1. Overview
    8.5.2. Influenza Market Forecast and Analysis
    8.6. HERPES
    8.6.1. Overview
    8.6.2. Herpes Market Forecast and Analysis
    8.7. CORONAVIRUS INFECTION
    8.7.1. Overview
    8.7.2. Coronavirus Infection Market Forecast and Analysis
    8.8. OTHERS
    8.8.1. Overview
    8.8.2. Others Market Forecast and Analysis
    9. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    9.1. OVERVIEW
    9.2. TYPE MARKET FORECASTS AND ANALYSIS
    9.3. BRANDED
    9.3.1. Overview
    9.3.2. Branded Market Forecast and Analysis
    9.4. GENERIC
    9.4.1. Overview
    9.4.2. Generic Market Forecast and Analysis
    10. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    10.1. OVERVIEW
    10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    10.3. HOSPITALS
    10.3.1. Overview
    10.3.2. Hospitals Market Forecast and Analysis
    10.4. RETAIL PHARMACIES
    10.4.1. Overview
    10.4.2. Retail Pharmacies Market Forecast and Analysis
    10.5. ONLINE PHARMACIES
    10.5.1. Overview
    10.5.2. Online Pharmacies Market Forecast and Analysis

    11. ANTIVIRAL DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    11.1. NORTH AMERICA
    11.1.1 North America Antiviral Drugs Market Overview
    11.1.2 North America Antiviral Drugs Market Forecasts and Analysis
    11.1.3 North America Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
    11.1.4 North America Antiviral Drugs Market Forecasts and Analysis - By Application
    11.1.5 North America Antiviral Drugs Market Forecasts and Analysis - By Type
    11.1.6 North America Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
    11.1.7 North America Antiviral Drugs Market Forecasts and Analysis - By Countries
    11.1.7.1 United States Antiviral Drugs Market
    11.1.7.1.1 United States Antiviral Drugs Market by Mechanism of Action
    11.1.7.1.2 United States Antiviral Drugs Market by Application
    11.1.7.1.3 United States Antiviral Drugs Market by Type
    11.1.7.1.4 United States Antiviral Drugs Market by Distribution Channel
    11.1.7.2 Canada Antiviral Drugs Market
    11.1.7.2.1 Canada Antiviral Drugs Market by Mechanism of Action
    11.1.7.2.2 Canada Antiviral Drugs Market by Application
    11.1.7.2.3 Canada Antiviral Drugs Market by Type
    11.1.7.2.4 Canada Antiviral Drugs Market by Distribution Channel
    11.1.7.3 Mexico Antiviral Drugs Market
    11.1.7.3.1 Mexico Antiviral Drugs Market by Mechanism of Action
    11.1.7.3.2 Mexico Antiviral Drugs Market by Application
    11.1.7.3.3 Mexico Antiviral Drugs Market by Type
    11.1.7.3.4 Mexico Antiviral Drugs Market by Distribution Channel
    11.2. EUROPE
    11.2.1 Europe Antiviral Drugs Market Overview
    11.2.2 Europe Antiviral Drugs Market Forecasts and Analysis
    11.2.3 Europe Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
    11.2.4 Europe Antiviral Drugs Market Forecasts and Analysis - By Application
    11.2.5 Europe Antiviral Drugs Market Forecasts and Analysis - By Type
    11.2.6 Europe Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
    11.2.7 Europe Antiviral Drugs Market Forecasts and Analysis - By Countries
    11.2.7.1 Germany Antiviral Drugs Market
    11.2.7.1.1 Germany Antiviral Drugs Market by Mechanism of Action
    11.2.7.1.2 Germany Antiviral Drugs Market by Application
    11.2.7.1.3 Germany Antiviral Drugs Market by Type
    11.2.7.1.4 Germany Antiviral Drugs Market by Distribution Channel
    11.2.7.2 France Antiviral Drugs Market
    11.2.7.2.1 France Antiviral Drugs Market by Mechanism of Action
    11.2.7.2.2 France Antiviral Drugs Market by Application
    11.2.7.2.3 France Antiviral Drugs Market by Type
    11.2.7.2.4 France Antiviral Drugs Market by Distribution Channel
    11.2.7.3 Italy Antiviral Drugs Market
    11.2.7.3.1 Italy Antiviral Drugs Market by Mechanism of Action
    11.2.7.3.2 Italy Antiviral Drugs Market by Application
    11.2.7.3.3 Italy Antiviral Drugs Market by Type
    11.2.7.3.4 Italy Antiviral Drugs Market by Distribution Channel
    11.2.7.4 Spain Antiviral Drugs Market
    11.2.7.4.1 Spain Antiviral Drugs Market by Mechanism of Action
    11.2.7.4.2 Spain Antiviral Drugs Market by Application
    11.2.7.4.3 Spain Antiviral Drugs Market by Type
    11.2.7.4.4 Spain Antiviral Drugs Market by Distribution Channel
    11.2.7.5 United Kingdom Antiviral Drugs Market
    11.2.7.5.1 United Kingdom Antiviral Drugs Market by Mechanism of Action
    11.2.7.5.2 United Kingdom Antiviral Drugs Market by Application
    11.2.7.5.3 United Kingdom Antiviral Drugs Market by Type
    11.2.7.5.4 United Kingdom Antiviral Drugs Market by Distribution Channel
    11.2.7.6 Rest of Europe Antiviral Drugs Market
    11.2.7.6.1 Rest of Europe Antiviral Drugs Market by Mechanism of Action
    11.2.7.6.2 Rest of Europe Antiviral Drugs Market by Application
    11.2.7.6.3 Rest of Europe Antiviral Drugs Market by Type
    11.2.7.6.4 Rest of Europe Antiviral Drugs Market by Distribution Channel
    11.3. ASIA-PACIFIC
    11.3.1 Asia-Pacific Antiviral Drugs Market Overview
    11.3.2 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis
    11.3.3 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
    11.3.4 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Application
    11.3.5 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Type
    11.3.6 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
    11.3.7 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Countries
    11.3.7.1 Australia Antiviral Drugs Market
    11.3.7.1.1 Australia Antiviral Drugs Market by Mechanism of Action
    11.3.7.1.2 Australia Antiviral Drugs Market by Application
    11.3.7.1.3 Australia Antiviral Drugs Market by Type
    11.3.7.1.4 Australia Antiviral Drugs Market by Distribution Channel
    11.3.7.2 China Antiviral Drugs Market
    11.3.7.2.1 China Antiviral Drugs Market by Mechanism of Action
    11.3.7.2.2 China Antiviral Drugs Market by Application
    11.3.7.2.3 China Antiviral Drugs Market by Type
    11.3.7.2.4 China Antiviral Drugs Market by Distribution Channel
    11.3.7.3 India Antiviral Drugs Market
    11.3.7.3.1 India Antiviral Drugs Market by Mechanism of Action
    11.3.7.3.2 India Antiviral Drugs Market by Application
    11.3.7.3.3 India Antiviral Drugs Market by Type
    11.3.7.3.4 India Antiviral Drugs Market by Distribution Channel
    11.3.7.4 Japan Antiviral Drugs Market
    11.3.7.4.1 Japan Antiviral Drugs Market by Mechanism of Action
    11.3.7.4.2 Japan Antiviral Drugs Market by Application
    11.3.7.4.3 Japan Antiviral Drugs Market by Type
    11.3.7.4.4 Japan Antiviral Drugs Market by Distribution Channel
    11.3.7.5 South Korea Antiviral Drugs Market
    11.3.7.5.1 South Korea Antiviral Drugs Market by Mechanism of Action
    11.3.7.5.2 South Korea Antiviral Drugs Market by Application
    11.3.7.5.3 South Korea Antiviral Drugs Market by Type
    11.3.7.5.4 South Korea Antiviral Drugs Market by Distribution Channel
    11.3.7.6 Rest of Asia-Pacific Antiviral Drugs Market
    11.3.7.6.1 Rest of Asia-Pacific Antiviral Drugs Market by Mechanism of Action
    11.3.7.6.2 Rest of Asia-Pacific Antiviral Drugs Market by Application
    11.3.7.6.3 Rest of Asia-Pacific Antiviral Drugs Market by Type
    11.3.7.6.4 Rest of Asia-Pacific Antiviral Drugs Market by Distribution Channel
    11.4. MIDDLE EAST AND AFRICA
    11.4.1 Middle East and Africa Antiviral Drugs Market Overview
    11.4.2 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis
    11.4.3 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
    11.4.4 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Application
    11.4.5 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Type
    11.4.6 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
    11.4.7 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Countries
    11.4.7.1 South Africa Antiviral Drugs Market
    11.4.7.1.1 South Africa Antiviral Drugs Market by Mechanism of Action
    11.4.7.1.2 South Africa Antiviral Drugs Market by Application
    11.4.7.1.3 South Africa Antiviral Drugs Market by Type
    11.4.7.1.4 South Africa Antiviral Drugs Market by Distribution Channel
    11.4.7.2 Saudi Arabia Antiviral Drugs Market
    11.4.7.2.1 Saudi Arabia Antiviral Drugs Market by Mechanism of Action
    11.4.7.2.2 Saudi Arabia Antiviral Drugs Market by Application
    11.4.7.2.3 Saudi Arabia Antiviral Drugs Market by Type
    11.4.7.2.4 Saudi Arabia Antiviral Drugs Market by Distribution Channel
    11.4.7.3 U.A.E Antiviral Drugs Market
    11.4.7.3.1 U.A.E Antiviral Drugs Market by Mechanism of Action
    11.4.7.3.2 U.A.E Antiviral Drugs Market by Application
    11.4.7.3.3 U.A.E Antiviral Drugs Market by Type
    11.4.7.3.4 U.A.E Antiviral Drugs Market by Distribution Channel
    11.4.7.4 Rest of Middle East and Africa Antiviral Drugs Market
    11.4.7.4.1 Rest of Middle East and Africa Antiviral Drugs Market by Mechanism of Action
    11.4.7.4.2 Rest of Middle East and Africa Antiviral Drugs Market by Application
    11.4.7.4.3 Rest of Middle East and Africa Antiviral Drugs Market by Type
    11.4.7.4.4 Rest of Middle East and Africa Antiviral Drugs Market by Distribution Channel
    11.5. SOUTH AND CENTRAL AMERICA
    11.5.1 South and Central America Antiviral Drugs Market Overview
    11.5.2 South and Central America Antiviral Drugs Market Forecasts and Analysis
    11.5.3 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
    11.5.4 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Application
    11.5.5 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Type
    11.5.6 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
    11.5.7 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Countries
    11.5.7.1 Brazil Antiviral Drugs Market
    11.5.7.1.1 Brazil Antiviral Drugs Market by Mechanism of Action
    11.5.7.1.2 Brazil Antiviral Drugs Market by Application
    11.5.7.1.3 Brazil Antiviral Drugs Market by Type
    11.5.7.1.4 Brazil Antiviral Drugs Market by Distribution Channel
    11.5.7.2 Argentina Antiviral Drugs Market
    11.5.7.2.1 Argentina Antiviral Drugs Market by Mechanism of Action
    11.5.7.2.2 Argentina Antiviral Drugs Market by Application
    11.5.7.2.3 Argentina Antiviral Drugs Market by Type
    11.5.7.2.4 Argentina Antiviral Drugs Market by Distribution Channel
    11.5.7.3 Rest of South and Central America Antiviral Drugs Market
    11.5.7.3.1 Rest of South and Central America Antiviral Drugs Market by Mechanism of Action
    11.5.7.3.2 Rest of South and Central America Antiviral Drugs Market by Application
    11.5.7.3.3 Rest of South and Central America Antiviral Drugs Market by Type
    11.5.7.3.4 Rest of South and Central America Antiviral Drugs Market by Distribution Channel

    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    13. ANTIVIRAL DRUGS MARKET, KEY COMPANY PROFILES
    13.1. F. HOFFMANN-LA ROCHE LTD
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. GLAXOSMITHKLINE PLC
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. MERCK SHARP AND DOHME CORP
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. GILEAD SCIENCES, INC
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. BRISTOL-MYERS SQUIBB COMPANY
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. JOHNSON AND JOHNSON SERVICES, INC.
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. MYLAN N.V (VIATRIS)
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. DR. REDDY'S LABORATORIES LTD
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. CIPLA INC
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. AUROBINDO PHARMA USA
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments

    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    - F. Hoffmann-La Roche Ltd
    - GlaxoSmithKline plc
    - Merck Sharp and Dohme Corp
    - Gilead Sciences, Inc
    - Bristol-Myers Squibb Company
    - Johnson and Johnson Services, Inc.
    - Mylan N.V (Viatris)
    - Dr. Reddy's Laboratories Ltd
    - Cipla Inc
    - Aurobindo Pharma USA
    - Glenmark
    - Genentech
    - Abbott
    - Himalaya Wellness Company
    TIPRE00004068
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking